ALHERT Trial
Cross-source consensus on ALHERT Trial from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Comparisons
Evidence quality
Other
Highlighted claims
- ALHERT is a multicentre cluster randomised controlled interventional trial conducted in 10 French academic centres. — Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial
- Five centres use usual care and five centres implement NEWS-guided care throughout the study. — Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial
- ALHERT tests whether repeated NEWS assessment plus immediate ICU admission at NEWS scores of 7 or higher improves outcomes in high-risk haematology patients. — Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial
- Cluster randomisation was selected to prevent NEWS exposure from changing clinician behaviour for control patients. — Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial
- The trial aims to validate early warning scores in a high-risk haematology setting where prospective controlled evidence is limited. — Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial